User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 2 results.
    • Journal article
    Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial.
    Wulf, Gerald G Altmann, Bettina Ziepert, Marita D'Amore, Francesco Held, Gerhard Greil, Richard Tournilhac, Olivier Relander, Thomas Viardot, Andreas Wilhelm, Martin Wilhelm, Christian Pezzutto, Antonio Zijlstra, Josee M Van Den Neste, Eric[UCL] Lugtenburg, Pieternella J Doorduijn, Jeanette K Gelder, Michel van van Imhoff, Gustaaf W Zettl, Florian Braulke, Friederike Nickelsen, Maike Glass, Bertram Rosenwald, Andreas Gaulard, Philippe Loeffler, Markus Pfreundschuh, Michael Schmitz, Norbert Trümper, Lorenz ACT-2 study investigators (2021) Leukemia — Vol. 35, no.1, p. 143-155 (2021)
    • Journal article
    R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK): final results of a multicentre, phase 3, open-label, randomised trial.
    Chamuleau, Martine E D Stenner, Frank Chitu, Dana A Novak, Urban Minnema, Monique C Geerts, Paul Stevens, Wendy B C Zenz, Thorsten van Imhoff, Gustaaf W Wu, Ka Lung Demandt, Astrid M P Kersten, Marie Jose Terpstra, Wim E Tick, Lidwine W Deeren, Dries Van Den Neste, Eric[UCL] Gregor, Michael Veelken, Hendrik Böhmer, Lara H Caspar, Clemens B Mutsaers, Pim Refos, Jeannine M Sewsaran, Robby Fu, Liping Seefat, Rianne L Uyl-de Groot, Carin A Dirnhofer, Stefan Van Den Brand, Michiel de Jong, Daphne Nijland, Marcel Lugtenburg, Pieternella (2023) The Lancet. Haematology — Vol. 10, no.12, p. e966-e975 (2023)